Cargando…

Barriers and facilitators to adherence to anti-diabetic medications: Ethiopian patients’ perspectives

BACKGROUND: Little is known about the experiences of Ethiopian patients with type 2 diabetes related to adherence to their anti-diabetic medications. This may limit attempts to develop and implement patient-centred approaches that consider Ethiopian contexts. OBJECTIVES: To conduct an exploratory st...

Descripción completa

Detalles Bibliográficos
Autores principales: Habte, Bruck M., Kebede, Tedla, Fenta, Teferi G., Boon, Heather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675919/
https://www.ncbi.nlm.nih.gov/pubmed/29113442
http://dx.doi.org/10.4102/phcfm.v9i1.1411
_version_ 1783276984143446016
author Habte, Bruck M.
Kebede, Tedla
Fenta, Teferi G.
Boon, Heather
author_facet Habte, Bruck M.
Kebede, Tedla
Fenta, Teferi G.
Boon, Heather
author_sort Habte, Bruck M.
collection PubMed
description BACKGROUND: Little is known about the experiences of Ethiopian patients with type 2 diabetes related to adherence to their anti-diabetic medications. This may limit attempts to develop and implement patient-centred approaches that consider Ethiopian contexts. OBJECTIVES: To conduct an exploratory study with a focus on identifying barriers and facilitators to anti-diabetic medications adherence in Ethiopian patients with type 2 diabetes. METHODS: Qualitative methods were used to conduct semi-structured interviews with 39 purposively selected participants attending clinic in three public hospitals in central Ethiopia. Open coding was used to analyse the data to identify key themes. RESULTS: A number of factors were identified as barriers and facilitators to participants’ adherence to their anti-diabetic medications. The most common factors were perceptions related to their illness including symptoms, consequences and curability; perceptions of medications including safety concerns, convenience and their necessity; religious healing practices and beliefs; perceptions about and experiences with their healthcare providers and the healthcare system including the availability of medications and diabetes education; and finally perceived self-efficacy and social support. CONCLUSIONS: The findings of this study provide guidance to strengthen diabetes education programmes so that they reflect local patient contexts focusing among other things on the illness itself and the anti-diabetic medications.
format Online
Article
Text
id pubmed-5675919
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher AOSIS
record_format MEDLINE/PubMed
spelling pubmed-56759192017-11-13 Barriers and facilitators to adherence to anti-diabetic medications: Ethiopian patients’ perspectives Habte, Bruck M. Kebede, Tedla Fenta, Teferi G. Boon, Heather Afr J Prim Health Care Fam Med Original Research BACKGROUND: Little is known about the experiences of Ethiopian patients with type 2 diabetes related to adherence to their anti-diabetic medications. This may limit attempts to develop and implement patient-centred approaches that consider Ethiopian contexts. OBJECTIVES: To conduct an exploratory study with a focus on identifying barriers and facilitators to anti-diabetic medications adherence in Ethiopian patients with type 2 diabetes. METHODS: Qualitative methods were used to conduct semi-structured interviews with 39 purposively selected participants attending clinic in three public hospitals in central Ethiopia. Open coding was used to analyse the data to identify key themes. RESULTS: A number of factors were identified as barriers and facilitators to participants’ adherence to their anti-diabetic medications. The most common factors were perceptions related to their illness including symptoms, consequences and curability; perceptions of medications including safety concerns, convenience and their necessity; religious healing practices and beliefs; perceptions about and experiences with their healthcare providers and the healthcare system including the availability of medications and diabetes education; and finally perceived self-efficacy and social support. CONCLUSIONS: The findings of this study provide guidance to strengthen diabetes education programmes so that they reflect local patient contexts focusing among other things on the illness itself and the anti-diabetic medications. AOSIS 2017-10-17 /pmc/articles/PMC5675919/ /pubmed/29113442 http://dx.doi.org/10.4102/phcfm.v9i1.1411 Text en © 2017. The Authors https://creativecommons.org/licenses/by/4.0/ Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License.
spellingShingle Original Research
Habte, Bruck M.
Kebede, Tedla
Fenta, Teferi G.
Boon, Heather
Barriers and facilitators to adherence to anti-diabetic medications: Ethiopian patients’ perspectives
title Barriers and facilitators to adherence to anti-diabetic medications: Ethiopian patients’ perspectives
title_full Barriers and facilitators to adherence to anti-diabetic medications: Ethiopian patients’ perspectives
title_fullStr Barriers and facilitators to adherence to anti-diabetic medications: Ethiopian patients’ perspectives
title_full_unstemmed Barriers and facilitators to adherence to anti-diabetic medications: Ethiopian patients’ perspectives
title_short Barriers and facilitators to adherence to anti-diabetic medications: Ethiopian patients’ perspectives
title_sort barriers and facilitators to adherence to anti-diabetic medications: ethiopian patients’ perspectives
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675919/
https://www.ncbi.nlm.nih.gov/pubmed/29113442
http://dx.doi.org/10.4102/phcfm.v9i1.1411
work_keys_str_mv AT habtebruckm barriersandfacilitatorstoadherencetoantidiabeticmedicationsethiopianpatientsperspectives
AT kebedetedla barriersandfacilitatorstoadherencetoantidiabeticmedicationsethiopianpatientsperspectives
AT fentateferig barriersandfacilitatorstoadherencetoantidiabeticmedicationsethiopianpatientsperspectives
AT boonheather barriersandfacilitatorstoadherencetoantidiabeticmedicationsethiopianpatientsperspectives